Despite concerns about the economic climate in Europe and whether or not the U.S. is headed into another recession, biotech companies around the world managed to raise $23.4 billion in 2011, up from $19.3 billion in 2010 and almost back on par with the $24.8 billion raised in the glory days of 2007.